🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Daniel Q. Huang

National University of Singapore

ORCID: 0000-0002-5165-5061

Also affiliated with National University Cancer Institute, Singapore, National University Hospital, National University Health System

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.733Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Updates in Characteristics and Survival Rates of Hepatocellular Carcinoma in a Nationwide Cohort of Real-World US Patients, 2003–2021

Journal of Hepatocellular Carcinoma(2023)10.2147/jhc.s420603
Top 27%
0.733DataRank
Top 27%23 citations

Biyao Zou, Leslie Y. Kam, KeeSeok Lee, Daniel Q. Huang, Linda Henry +3 more

Papers

Driven by 10 papers — median percentile 73. Top paper: “Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study”.

Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study

Gastroenterology(2023)10.1053/j.gastro.2023.04.025
N/A
4.7DataRank · unranked
175 citations

Laura Wilson, Cynthia Behling, David E. Kleiner, Kris V. Kowdley, Srinivasan Dasarathy +73 more

Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer

Cell Metabolism(2022)10.1016/j.cmet.2022.05.003
N/A
0.938DataRank · unranked
520 citations

Amit G. Singal, Yuko Kono, Darren Jun Hao Tan, Hashem B. El‐Serag, Rohit Loomba +1 more

Updates in Characteristics and Survival Rates of Hepatocellular Carcinoma in a Nationwide Cohort of Real-World US Patients, 2003–2021

Journal of Hepatocellular Carcinoma(2023)10.2147/jhc.s420603
Top 27%
0.733DataRank
Top 27%23 citations

Biyao Zou, Leslie Y. Kam, KeeSeok Lee, Daniel Q. Huang, Linda Henry +3 more

Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Advances in Therapy(2023)10.1007/s12325-023-02618-7
N/A
0.257DataRank · unranked
4 citations

Veeral Ajmera, Christian Tomaszewski, Andrew Lafree, Ricki Bettencourt, Wesley K. Thompson +24 more

Global Trend of MASH-associated Liver Cancer: A Systematic Analysis From the Global Burden of Disease 2021

Clinical Gastroenterology and Hepatology(2024)10.1016/j.cgh.2024.10.026
N/A
0DataRank · unranked
12 citations

Kanokphong Suparan, Chuthatip Kaeosri, Pimtawan Jatupornpakdee, Abdelrahman M. Attia, Thanathip Suenghataiphorn +8 more

Changing global epidemiology of chronic hepatitis C virus-related outcomes from 2010 to 2019: cirrhosis is the growing burden of hepatitis C virus-related disease

European Journal of Cancer Prevention(2024)10.1097/cej.0000000000000885
N/A
0DataRank · unranked
9 citations

Daniel Q. Huang, Zhongjie Zhang, Cheng Han Ng, Darren Jun Hao Tan, Hiep Chi Nguyen +5 more

Impact of Model for End-stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates

Clinical Gastroenterology and Hepatology(2025)10.1016/j.cgh.2025.10.016
N/A
0DataRank · unranked
0 citations

Darren Jun Hao Tan, Kartik Mitra, Margaret Teng, Cheng Han Ng, Donghyun Ko +15 more

Review article: current and emerging therapies for the management of cirrhosis and its complications

Alimentary Pharmacology & Therapeutics(2022)10.1111/apt.16831
N/A
0DataRank · unranked
37 citations

Nneka N. Ufere, Daniel Q. Huang, Rohit Loomba, Elliot B. Tapper

IL-18 is required for the TH1-adaptation of TREG cells and the selective suppression of TH17 responses in acute and chronic infections

Mucosal Immunology(2023)10.1016/j.mucimm.2023.05.004
N/A
0DataRank · unranked
17 citations

Roman Istomine, Alonso da Silva Lira Filho, Tho-Alfakar Al-Aubodah, Daniel Q. Huang, Rakan Okde +4 more

Cost-Effectiveness Analysis of Hepatocellular Carcinoma Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis Using US Visualization Score C–Triggered Abbreviated MRI

The American Journal of Gastroenterology(2023)10.14309/ajg.0000000000002636
N/A
0DataRank · unranked
15 citations

Daniel Q. Huang, Harris Siddiqi, Kathryn J. Fowler, Claude B. Sirlin, Robert M. Marks +3 more